Recently Updated NPI Information — some details in this NPI profile have been updated in the NPI registry within the last 60 days.

RACHEL JACOB TESKE CRNP
Prescription History 1821777921
Nurse Practitioner - Family in Philadelphia, PA

Active since July 17, 2023PECOS EnrolledAccepts Medicare Assignment
6129 PALMETTO ST, PHILADELPHIA, PA 19111(215) 268-1720(215) 722-8516 Get Directions

NPPES record last updated: September 10, 2026. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Sep 10, 2026, Mar 4, 2026, Dec 7, 2023 and 1 more (4 updates tracked since 2023).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for RACHEL JACOB TESKE CRNP, an active Family specialist practicing in Philadelphia, PA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Tresiba Flextouch U-100, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
16
30-Day Fills
Tresiba Flextouch U-100
Most Prescribed · 12 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by RACHEL JACOB TESKE CRNP in 2024, with prescription volumes, average cost per fill, and PA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other PA PrescribersVs. PA Avg
Tresiba Flextouch U-100Insulin Degludec12$465.34▼ below PA avg▼ Less than typical

About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2024, this provider wrote 12 Medicare prescriptions for Tresiba Flextouch U-100, about a third of the volume of the typical Pennsylvania prescriber of this medication (31.7). Medicare paid an average of $465.34 per fill, versus $646.06 statewide.

How often this provider prescribes it

This provider
12
PA average
31.7

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$465.34
PA average
$646.06

This provider's average cost per fill is below the PA average for this medication.

16.1
30-Day Fills
standardized to 30-day supplies
483
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average PA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the PA average cost per fill.

About this data. The prescription history for RACHEL JACOB TESKE CRNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Philadelphia, PA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.